SEARCH

SEARCH BY CITATION

References

  • 1
    Thomas CB, Cohen BH. The familial occurrence of hypertension and coronary artery disease, with observations concerning obesity and diabetes. Ann Intern Med 1955;42:90127.
  • 2
    Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:17241737.
  • 3
    Sampalis JS, Sampalis F, Christou N. Impact of bariatric surgery on cardiovascular and musculoskeletal morbidity. Surg Obes Relat Dis 2006;2:587591.
  • 4
    Sjöström L, Narbro K, Sjöström CD et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007;357:741752.
  • 5
    Pories WJ, Swanson MS, MacDonald KG et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339350 50; discussion.
  • 6
    Habib P, Scrocco JD, Terek M, Vanek V, Mikolich JR. Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis. Am J Cardiol 2009;104:12511255.
  • 7
    Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109:III27III32.
  • 8
    Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 2008;93:S64S73.
  • 9
    Stein JH, Korcarz CE, Hurst RT et al.; American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008;21:93189 111; quiz.
  • 10
    Corretti MC, Anderson TJ, Benjamin EJ et al.; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257265.
  • 11
    Constans J, Conri C. Circulating markers of endothelial function in cardiovascular disease. Clin Chim Acta 2006;368:3347.
  • 12
    Wang JJ, Liew G, Klein R et al. Retinal vessel diameter and cardiovascular mortality: pooled data analysis from two older populations. Eur Heart J 2007;28:19841992.
  • 13
    McGeechan K, Liew G, Macaskill P et al. Risk prediction of coronary heart disease based on retinal vascular caliber (from the Atherosclerosis Risk In Communities [ARIC] Study). Am J Cardiol 2008;102:5863.
  • 14
    Wang JJ, Mitchell P, Leung H et al. Hypertensive retinal vessel wall signs in a general older population: the Blue Mountains Eye Study. Hypertension 2003;42:534541.
  • 15
    Leung H, Wang JJ, Rochtchina E et al. Relationships between age, blood pressure, and retinal vessel diameters in an older population. Invest Ophthalmol Vis Sci 2003;44:29002904.
  • 16
    Wong TY, Klein R, Klein BE, Meuer SM, Hubbard LD. Retinal vessel diameters and their associations with age and blood pressure. Invest Ophthalmol Vis Sci 2003;44:46444650.
  • 17
    Ikram MK, de Jong FJ, Vingerling JR et al. Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. Invest Ophthalmol Vis Sci 2004;45:21292134.
  • 18
    Wang JJ, Taylor B, Wong TY et al. Retinal vessel diameters and obesity: a population-based study in older persons. Obesity (Silver Spring) 2006;14:206214.
  • 19
    Liew G, Sharrett AR, Wang JJ et al. Relative importance of systemic determinants of retinal arteriolar and venular caliber: the atherosclerosis risk in communities study. Arch Ophthalmol 2008;126:14041410.
  • 20
    Dorner GT, Garhofer G, Kiss B et al. Nitric oxide regulates retinal vascular tone in humans. Am J Physiol Heart Circ Physiol 2003;285:H631H636.
  • 21
    Dorner GT, Garhöfer G, Huemer KH et al. Hyperglycemia affects flicker-induced vasodilation in the retina of healthy subjects. Vision Res 2003;43:14951500.
  • 22
    Polak K, Schmetterer L, Riva CE. Influence of flicker frequency on flicker-induced changes of retinal vessel diameter. Invest Ophthalmol Vis Sci 2002;43:27212726.
  • 23
    Takano T, Tian GF, Peng W et al. Astrocyte-mediated control of cerebral blood flow. Nat Neurosci 2006;9:260267.
  • 24
    Mandecka A, Dawczynski J, Blum M et al. Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care 2007;30:30483052.
  • 25
    Garhöfer G, Zawinka C, Resch H et al. Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes. Br J Ophthalmol 2004;88:887891.
  • 26
    Pemp B, Weigert G, Karl K et al. Correlation of flicker-induced and flow-mediated vasodilatation in patients with endothelial dysfunction and healthy volunteers. Diabetes Care 2009;32:15361541.
  • 27
    Grundy SM, Cleeman JI, Daniels SR et al.; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:27352752.
  • 28
    Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 2002;105:310315.
  • 29
    National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) et al. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002;106:31433421.
  • 30
    Wong TY, Klein R, Couper DJ et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 2001;358:11341140.
  • 31
    Kawasaki R, Tielsch JM, Wang JJ et al. The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata study. Br J Ophthalmol 2008;92:161166.
  • 32
    Shechter M, Issachar A, Marai I et al. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. Int J Cardiol 2009;134:5258.
  • 33
    Gokce N, Vita JA, McDonnell M et al. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Am J Cardiol 2005;95:266268.
  • 34
    Wang JJ, Liew G, Wong TY et al. Retinal vascular calibre and the risk of coronary heart disease-related death. Heart 2006;92:15831587.
  • 35
    Zhu W, Cheng KK, Vanhoutte PM, Lam KS, Xu A. Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci 2008;114:361374.
  • 36
    de la Torre García N., Rubio MA, Bordiú E, et al. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin. J Clin Endocrinol Metab 2008;93:42764281.
  • 37
    Ziccardi P, Nappo F, Giugliano G et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002;105:804809.
  • 38
    Konukoglu D, Uzun H, Firtina S et al. Plasma adhesion and inflammation markers: asymmetrical dimethyl-L-arginine and secretory phospholipase A2 concentrations before and after laparoscopic gastric banding in morbidly obese patients. Obes Surg 2007;17:672678.
  • 39
    Williams IL, Chowienczyk PJ, Wheatcroft SB et al. Endothelial function and weight loss in obese humans. Obes Surg 2005;15:10551060.
  • 40
    Batsis JA, Sarr MG, Collazo-Clavell ML et al. Cardiovascular risk after bariatric surgery for obesity. Am J Cardiol 2008;102:930937.